Edward J. Benz JR - 26 Jul 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Edward J. Benz, Jr.
Issuer symbol
CADL
Transactions as of
26 Jul 2021
Net transactions value
$0
Form type
3
Filing time
26 Jul 2021, 21:24:01 UTC
Previous filing
25 Jun 2021
Next filing
08 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CADL Stock Option (Right to Buy) 26 Jul 2021 Common Stock 32,548 $1.46 Direct F1
holding CADL Stock Option (Right to Buy) 26 Jul 2021 Common Stock 4,068 $1.46 Direct F2
holding CADL Stock Option (Right to Buy) 26 Jul 2021 Common Stock 16,274 $1.55 Direct F3
holding CADL Stock Option (Right to Buy) 26 Jul 2021 Common Stock 16,274 $6.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in four substantially equal annual installments, with the first installment vested on October 4, 2018.
F2 25% of this option vested and became exercisable on May 28, 2019, with an additional 25% vesting on January 1, 2020 and the remainder vesting in 36 substantially equal monthly installments thereafter.
F3 This option is fully vested and exercisable as of the date hereof.